MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Subthalamic nucleus(SIN)"

  • 2025 International Congress

    Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study

    J. Li, A. Li, C. Zhang (Shanghai, China)

    Objective: To investigate whether transcranial temporal interference stimulation (tTIS) targeting different deep brain regions produces symptom-specific improvements consistent with established deep brain stimulation (DBS) outcomes…
  • 2025 International Congress

    Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

    T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To compare subthalamic nucleus (STN) perfusion changes following mesenchymal stem cell (MSC) infusion in Parkinson’s disease (PD) using Bayesian methods in both Phase I…
  • 2025 International Congress

    Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

    š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To evaluate the impact of patient-specific structural connectivity between VTA in STN targeting and SMA/preSMA on functional mobility improvements in PD patients undergoing DBS.…
  • 2025 International Congress

    Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease

    O. Alenikova, M. Dymkovskaya, A. Bunyak, E. Mykitchuk, S. Kantsevich (Minsk, Belarus)

    Objective: We aimed to determine the predictors of cognitive decline and mood disorders after STN-DBS in PD. Background: Cognitive impairment and mood disorders are the…
  • 2025 International Congress

    Subthalamic Nucleus Stimulation May Suppress Both Ipsilateral and Contralateral Local-Field-Potential Magnitude

    B. Chase, M. Avenali, S. Malaspina, R. Zangaglia, K. Markopoulou (Evanston, USA)

    Objective: Determine whether ipsilateral subthalamic nucleus (STN) stimulation affects local field potential (LFP) power in the contralateral STN to inform clinical decision making. Background: A…
  • 2025 International Congress

    Traditional Deep Brain Stimulation Programming versus Automated Image-Guided Algorithm in Patients with Parkinson’s Disease

    H. Maghzi, C. Kim, S. Worthge, C. Malatt, M. Tagliati (Los Angeles, USA)

    Objective: To compare traditional initial deep brain stimulation (DBS) programming with artificial intelligence (AI)-assisted automated image-guided DBS programming algorithm. Background: DBS programming is a complex,…
  • 2025 International Congress

    Deep Brain Stimulation (DBS) Placement in a Patient with Parkinson’s disease (PD) and Polyostotic Fibrous Dysplasia (PFD)

    D. Kaul, P. Pezeshkian, E. Call, S. Nandipati, D. Bruce, M. Cochran Abraham, S. Khandhar (Walnut Creek, USA)

    Objective: To describe a patient who has PD and a history of PFD implanted with DBS. Background: PD is the second most common neurogenerative disorder…
  • 2025 International Congress

    Joint Prediction of Motor and Non-motor Deep Brain Stimulation Outcomes using Quantitative Susceptibility Mapping

    A. Roberts, S. Akkus, M. Spadaccia, C. Tozlu, D. Romano, P. Spincemaille, Y. Wang, B. Kopell (Ithaca, USA)

    Objective: To jointly estimate motor and non-motor outcomes of deep brain stimulation using presurgical quantitative susceptibility maps. Background: Parkinson’s disease (PD) patients with motor complications…
  • 2025 International Congress

    Clinical Diversity Of Patients Attending To The Istanbul Medipol University Parkinson’s Disease And Movement Disorders Center (Parmer) Who Did Not Undergo Dbs Surgery

    OZG. Koksal, GLN. Ibrahimova, SED. Bostan, BSK. Bolluk Kılıc, NES. Helvaci Yılmaz, YAK. özsezer, BUS. Ari, ALI. Zirh, GUL. Kenangil (istanbul, Turkey)

    Objective: Patients diagnosed with PD and other movement disorders should be evaluated for alternative treatment approaches including Deep Brain Stimulation(DBS). In this study, we aimed…
  • 2025 International Congress

    A Double-Blind, Cross-Over Pilot Study Comparing Adaptive Deep Brain Stimulation (aDBS) to Conventional DBS in Parkinson’s Disease

    T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)

    Objective: To compare the efficacy of adaptive deep brain stimulation (aDBS) to conventional DBS (cDBS) in Parkinson’s disease through a double-blind, cross-over pilot study. Background:…
  • 1
  • 2
  • 3
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley